[Trastuzumab, a new treatment approach in breast carcinoma]

Internist (Berl). 2001 Jun;42(6):835-40, 842. doi: 10.1007/s001080170126.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / immunology
  • Breast Neoplasms / mortality
  • Clinical Trials as Topic
  • Drug Approval
  • Female
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / immunology
  • Receptor, ErbB-2 / immunology
  • Survival Rate
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Receptor, ErbB-2
  • Trastuzumab